Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: A novel gene expression signature-based on B-cell proportion to predict prognosis of patients with lung adenocarcinoma

Fig. 4

Immunohistochemical analysis of patients in high-risk group and low-risk group. (A) H&E representative pictures and immunohistochemical representative pictures of anti-CD3, anti-CD4, anti-CD8, anti-CD19, anti-CD20, and anti-PD1 in high-risk LUAD patients. (B) The IHC-score of those above antigens in low-risk group and high-risk group. (C) B-lineage-associated risk signature and immunotherapy benefit distribution heatmap

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us